Statins and long-term risk of revision surgery after total hip arthroplasty in osteoarthritis: a multi-source data linkage study
Our findings suggest that statin treatment is associated with a decreased risk of long-term THA revision in patients with OA, irrespective of the original indication for statin therapy.
Authors
- Andrea D’Amuri (ORCID: https://orcid.org/0000-0002-7421-0014)
- Claudio D’Agostino (ORCID: https://orcid.org/0000-0003-2616-0662)
- Barbara Bordini (ORCID: https://orcid.org/0000-0002-6606-4950)
- Francesco Ursini (ORCID: https://orcid.org/0000-0001-8194-8642)
- Jacopo Ciaffi (ORCID: https://orcid.org/0000-0002-9446-7351)
- Mauro Pagani (ORCID: https://orcid.org/0000-0002-0591-5416)
- Alberto Di Martino (ORCID: https://orcid.org/0000-0002-0716-4951)
- Cesare Faldini (ORCID: https://orcid.org/0000-0001-8152-4778)
Institutions
- Istituto Ortopedico Rizzoli (IT)
- Azienda Ospedaliera Carlo Poma (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.3389/fphar.2025.1492200
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00